News

“DGX Cloud Lepton is connecting Europe’s developers to a global AI infrastructure,” said Jensen Huang, founder and CEO of NVIDIA. “With partners across the region, we’re building a network of AI ...
BRAINBiocatalysts experienced modest organic growth in the first half of the year BRAINBioIncubator with high basis for comparison in the previous year Strong liquidity maintained at €14.9 million ...
BRAIN Biotech Group generated €25.2 million in revenue during the first half of the fiscal year, which is a 7.2 % decrease from the previous year (€27.2 million). This decline is primarily due ...
Breatec B.V. is now fully owned by BRAIN Biotech AG following a minority buyout New and enlarged production site will open close to Eindhoven, NL Expanded competence center for enzyme-based baking ...
Revenue: €12.5m (down 14% from 2Q 2024). Net loss: €3.06m (loss widened by 60% from 2Q 2024). €0.14 loss per share (further deteriorated from €0.088 loss in 2Q 2024). AI is about to change ...
Psilocybin induces consistent and sustained changes in brain network connectivity, particularly between the hippocampus and ...
Revenue: €12.5m (down 14% from 2Q 2024). Net loss: €3.06m (loss widened by 60% from 2Q 2024). €0.14 loss per share (further deteriorated from €0.088 loss in 2Q 2024). AI is about to change healthcare.
A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...